Industries — page 17
Berkshire Hathaway operating earnings rise to $12.98 billion
Net earnings attributable to shareholders rose to $25.67 billion in the second quarter
Black Rock Coffee Bar Raises 2026 Opening and Ebitda Targets
The company lifted full-year 2026 adjusted EBITDA to $34 million to $35 million and store openings to 38 after a 25.0% year-over-year revenue increase.
Aramark Raises Revenue Outlook as Client Wins Build
Third-quarter revenue reached $5.06 billion as growth broadened across the food-services provider.
Unusual Machines to Buy Upgrade Energy in $52 Million Cash-and-Stock Deal
The acquisition would add domestic battery engineering and manufacturing capacity to the drone-component maker.
Sentynl Therapeutics to Acquire Alvelestat Rights in $475 Million Asset Deal
The acquisition expands Sentynl's rare disease portfolio with a potential first-in-class oral treatment for alpha-1 antitrypsin deficiency with liver disease.
Joby Aviation to Acquire Resonant Sciences in $500 Million Defense Deal
The eVTOL maker is building a defense platform by adding classified capabilities and scaled manufacturing through its second acquisition in a year.
IES Holdings to Buy DBM Global in $685 Million Mixed Deal
The acquisition establishes a new structural line of business for IES to capitalize on industrial reshoring and data center demand.
Cardinal Infrastructure to Buy Allied Paving in $120 Million Mixed Deal
The acquisition brings paving capabilities in-house for the Atlanta-based contractor, extending its vertical-integration strategy into a new market.
Casualty Costs Rise as Catastrophe Pressure Eases for Insurers
A split is emerging in US insurance loss trends, with specialty and casualty lines deteriorating even as property catastrophe pressures ease.
Telos Raises Full-Year Profit Outlook on Telos ID
Second-quarter revenue reached $47.7 million, up 33% from a year earlier, and the company lifted full-year Adjusted EBITDA to as much as $28.6 million.
Target Hospitality Raises Full-Year Outlook as Revenue Climbs 39%
The company increased its full-year revenue guidance by 11% to a range of $410 million to $420 million.
Simon Property Group Raises Full-Year Outlook on NOI Growth
The real estate investment trust increased its full-year Real Estate FFO per share guidance midpoint by $0.08.
Outdoor Holding Extends Revenue Growth as Profitability Widens
Net revenues rose 22.1% to $14.5 million in the fiscal first quarter ended June 30, 2026, and Adjusted EBITDA more than doubled to $7.9 million.
PennantPark’s Net Asset Value Decline Slows
Net asset value fell 2.5% in the June quarter, while investment earnings remained below the company’s combined base and supplemental distributions.
Palisade Bio Clears IND and Starts Phase 2 Ulcerative Colitis Trial
Cash and cash equivalents stood at $125.2 million as of June 30, 2026, which the company said is sufficient through Phase 2 readouts expected in the second half of 2027 and early 2028.
Oruka Therapeutics Doubles Cash to $1.1 Billion, Accelerates Key Trial Readouts
The biotech's $700 million April offering swelled its balance sheet and pushed EVERLAST-B data a quarter ahead of schedule.
National Energy Services Reunited Posts Record Quarter as Margins Expand
National Energy Services Reunited (NESR) reported revenue of $520.8 million in the second quarter, up 59.1% from a year earlier and up 28.7% from the first quarter.
MITT Signs Cherry Hill Merger After Book Value Recovers
The residential mortgage REIT posted $0.24 of earnings available for distribution a share, matching its dividend, and lifted book value to $10.00.
James River Cuts Specialty Admitted Premiums to Chase E&S
Gross written premium fell 29% to $268.9 million as Specialty Admitted collapsed 76% and group retention rose to 55%.
GoPro Board Authorizes Sale Process as Revenue Falls
Second-quarter revenue was $105 million, down 31% from a year earlier, as hardware sales and retail demand continued to contract.
Greystone Housing Impact Investors Posts a Net Loss
Cash available for distribution was $2.43 million, or $0.10 a BUC, as the partnership booked a $1.52 million net loss.
FutureFuel Returns to Profit With Hedging Benefit
FutureFuel reported second-quarter net income of $11.4 million, reversing losses as biofuel production recovered and hedge-related timing benefits lifted gross profit.
Ferguson Raises Outlook as U.S. Sales Accelerate
Reported earnings rose 6.9% to $3.43 a share as share count declined.
Energy Services of America Raises Dividend After Profit Jump
Net income reached $3.3 million, or $0.18 a share, and the quarterly dividend rose 33% to $0.04 a share.
Ceco Raises Outlook as Thermon Deal Accelerates Growth
Second-quarter revenue climbed 54% to $285.0 million as the Thermon acquisition entered the results.
Crescent BDC NAV Falls Again After Fee Cuts
Net investment income was $0.36 a share in the quarter ended June 30, 2026, and NAV per share was $17.82.
Perspective Targets Year-End Phase 3 Start for VMT-α-NET
Cash, cash equivalents, and short-term investments were about $237 million as of June 30, 2026, a level the company said should fund planned clinical milestones into late 2027.
BRT Agrees To Buy Bradenton Apartments For About $80 Million
Combined portfolio NOI was $15.2 million in the second quarter, with FFO and AFFO unchanged at $0.29 and $0.36 a share.
AirSculpt Cuts 2026 Adjusted EBITDA Outlook
Adjusted EBITDA was $4.9 million in the second quarter as same-center sales stayed stable and the company lowered its profit range to about $12 million to $14 million.
WEBTOON to Buy RI Games in $100 Million Mixed-Structure Deal
The webcomics platform is building an in-house pipeline to turn hit series into mobile and interactive games.
Teledyne to Buy Varex Imaging in $1.1 Billion All-Cash Deal
The transaction would add complementary X-ray technologies to Teledyne’s portfolio and support faster development of advanced imaging products.
Zymeworks to Buy Theravance Biopharma in $929 Million Cash Deal
The acquisition, structured with a contingent value right tied to ampreloxetine, caps a multiyear strategic review at the COPD-focused biopharmaceutical company.
RUM Group to Acquire Northern Data AG in Strategic AI Infrastructure Deal
The acquisition combines scaled AI compute with a video creator community to establish a new cloud and AI-infrastructure business unit.
Rocket Lab to Buy Iridium in $8 Billion Cash-and-Stock Deal
The acquisition would create a vertically integrated space company spanning launch, satellite manufacturing, spectrum, and on-orbit communications services.
Ryman to Buy Grande Lakes Orlando in $1.38 Billion Asset Deal
The resort would extend Ryman’s luxury-hotel network and deepen its presence in the nation’s top meetings market.
Quantum Computing to Buy NHanced Semiconductors in $73.1 Million Mixed Deal
The acquisition launches QCi's second fabrication facility years ahead of schedule, adding advanced packaging and photonic integration capacity to the company's commercialization roadmap.
Ondas to Buy Cyberhawk in $125 Million Mostly Cash Deal
The acquisition would extend Ondas from autonomous data collection into software-enabled inspection and AI-driven infrastructure intelligence.
Jazz Pharmaceuticals to Buy Actio Biosciences in $820 Million Mixed Deal
The acquisition of ABS-1230 aims to expand Jazz's rare epilepsy portfolio and build upon the success of Epidiolex.
Safe Harbor to Buy MarineMax in $1.5 Billion All-Cash Deal
Blackstone-backed Safe Harbor Marinas agreed to take the yacht retailer and marina operator private at a 96% premium, capping a competitive strategic review of the company's future.
HBT Financial to Buy Tri-County Financial Group in $204.6 Million Deal
The mixed cash-and-stock deal deepens HBT's roots in central Illinois and pushes further into the Chicago metro area, echoing the bank's own acquisition playbook.
California Resources to Buy Crimson Midstream Pipeline Assets for $63 Million
The all-cash deal for Crimson's California pipeline and storage network extends CRC's push to knit its upstream production together with the infrastructure that moves it.
AbbVie to Buy Apogee Therapeutics in $10.9 Billion Cash Deal
AbbVie's all-cash purchase of the clinical-stage biotech adds a late-stage IL-13 antibody and a broader inflammatory-disease pipeline to its immunology franchise as Humira sales continue to erode.
Amneal Completes Acquisition of Kashiv BioSciences
The deal knits Kashiv's biosimilars manufacturing and pipeline into Amneal's commercial network, giving the company a platform aimed at more than $300 billion in biologics set to lose patent protection over the next decade.
Archer Aviation to Acquire Boeing's Wisk Aero, Insitu and SkyGrid Units
The deal folds a $200 million-plus defense revenue stream and autonomy software from three Boeing subsidiaries into Archer's air-taxi platform, betting on physical AI as its next growth leg.
Oneok Maintains Steady Footprint via Coronado Midstream Operations
The company reported a period of operational stability with no major rate adjustments or system extensions across its New Mexico and Texas transmission assets.
Kinder Morgan Manages Regulatory Contingencies Across Diversified Pipeline Fleet
The energy infrastructure giant navigated a complex web of commitments and contingencies across five key operating subsidiaries in 2024.
CenterPoint Energy Secures Recovery for Storm Costs and Rate Adjustments
The Houston-based utility moves to amortize winter storm bad debt and securitize $1.1 billion in Hurricane Beryl restoration expenses.
Ziff Davis Posts EPS Rebound as Revenue Declines
Free cash flow doubled from a year earlier to $54.0 million.
Wendy’s Withdraws Outlook as U.S. Sales Slide
Second-quarter revenue rose 1.7% to $570.6 million even as restaurant traffic remained under pressure.
Vistra Reaffirms 2026 Outlook After Helix and Cogentrix
Ongoing Operations Adjusted EBITDA reached $1,767 million, up more than 30% from a year earlier, as the company locked in 2026 volumes and kept its $6.8 billion to $7.6 billion range.